BackBiomm S.A. Overview

Biomm S.A. EBIT

Track Biomm S.A.'s EBIT ($53M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$9.87M
↑ 176.85% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$53.11M
↑ 185.81% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Biomm S.A. (BIOM3.SA) FAQ

The latest EBIT for BIOM3.SA is $53M as of June 2026. That compares with $-62M in the prior-year period — up 185.8% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside Biomm S.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOM3.SA's EBIT moved from $-62M to $53M — a 185.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biomm S.A.'s operating scale or balance-sheet position.

Against Healthcare companies, BIOM3.SA currently prints $53M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Biomm S.A.'s growth, margins, and balance sheet.

A EBIT figure of $53M for BIOM3.SA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting BIOM3.SA's EBIT ($53M), review year-over-year change from $-62M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers